|
Acetyl Salicylic Acid 100 Mg, Tablet, Amiodarone, 200Mg Tablet, Bisacodyl 5Mg, Captopril 25Mg, Clonidine, De Hydrochloride, 0, 100Mg Tablet, Clopidogrel 75 Mg, Dexchlorpheniramine 2 Mg, Loratadine 10Mg, Dipyrone 500Mg, Pantoprazole 40Mg, Isosorbide, Dinitrate, 5Mg Sublingual Tablet, Mononitrate, 20Mg Tablet, Paracetamol, 500Mg Tablet, Prednisone, 20Mg Fractional Tablet, Dexchlorpheniramine, Oral Solution 0.4 Mg/Ml Bottle With 100Ml., Dipyrone, Sodica 50Mg/Ml, Oral Solution, Bottle With 20Ml., Ipratropium Bromide, 025 Oral Solution 0. 25Mg/Ml Bottle 20Ml, Drops 200Mg/Ml, Bottle With 15Ml., Simethicone 75Mg/Ml Oral Emulsion, Bottle 10Ml., Fenoterol, Hydrobromide, Oral Solution 5Mg/Ml Bottle 20Ml, Salbutamol Sulfate 5Mg/Ml Nebulizer Solution 10Ml, Ketoconazole 20Mg/G Cream Tube 30G., Collagenase Chloramphenicol, Topical Ointment (0.6Ui 0.01G)G Tube With 30G, The Product Packaging Should Contain The Following Print: Sale Prohibited By Commerce. Present Registration Of Products With Anvisa And Certificate Of Good Practices, Manufacturing And Control - Cbpfc From The Manufacturer According To Anvisa Resolution No. 460/99., Dexamethasone Acetate, Cream 0, 1 Tb. 10G., Neomycin, Sulfate 5 Mg/G. Dermatological Ointment. Tube With 10 G., Bacitracin Sulfate (5Mg 250Ui)/G Ointment, Tube With 15 Grams, Betamethasone, Dipropionate, 5 Mg/G Gentamicin Sulfate 1Mg/G, Dermatological Ointment 30G., Betamethasone Ketoconazole Dipropionate Neomycin Sulfate 200, 52, 5 Mg/G Cream, Ferric Chloride 50, Hemostatic Gel For Use In High Frequency Surgery And Post-Cervical Biopsy, 10G, Lidocaine, Hydrochloride 2, Jelly 20Mg/G Tube, With 30Gr., 100Mg/Ml(10), Spray, Bottle With 50Ml., Polycresulene 360 Mg/G Topical Solution Concentration 12 Ml, Atropine 1 Ophthalmic Solution, 5Ml Bottle, Fluorescein, 10Mg/Ml Ophthalmic Solution, 3Ml Bottle. The Product Packaging Must Contain The Following Printing: Sale Prohibited By Commerce. Present Registration Of Products With Anvisa And Certificate Of Good Practices, Manufacturing And Control - Cbpfc Of The Manufacturer In Accordance With Anvisa Resolution No. 460/99. In The Case Of A Manufacturer Outside Mercosur, Present A Document From The Country Of Origin Translated By An Official Translator., Tropicamide 0.01G/Ml Ophthalmic Solution Bottle With 5Ml. The Product Packaging Must Contain The Following Printing: Sale Prohibited By Commerce. Present Product Registration With Anvisa And Certificate Of Good Practices, Phenylephrine, Hydrochloride 100Mg/Ml (10), Ophthalmic Solution, Bottle With 5 Ml. The Product Packaging Must Contain The Following Printing: Sale Prohibited By Commerce. Present Product Registration With Anvisa And Certificate Of Good Practices, Oxybuprocaine, Hydrochloride, 4 Mg/Ml (0, 4), Sterile Ophthalmic Solution, Bottle With 10Ml. The Product Packaging Must Contain The Following Printing: Sale Prohibited By Commerce. Present Product Registration With Anvisa And Certificate Of Good Practices, Adenosine 3Mg/Ml, Ampoule Injectable Solution 2Ml, The Packaging Must Contain The Imprint Sales Prohibited By Commerce. Present Product Registration With Anvisa And Certificate Of Good Practices, 50Mg/Ml, Solution, Injectable Hydrochloride 3Ml Ampoule, Manufacturing And Control - Manufacturers Cbpfc According To Anvisa Resolution No. 460/99, Atropine, Sulfate, Injectable Solution, 5 Mg/Ml 1Ml Ampoule, Tranexamic Acid 50Mg/Ml 5 Ml 50 Mg/Ml Injectable Solution. Packaging Containing 5 Ampoules With 5 Ml, Betamethasone Dipropionate, Disodium Phosphate (5Mg2mg)/Ml Injectable Suspension 1Ml, Bicarbonate
|
